26.03.2019 – 15:29 Mallinckrodt Announces 2019 Investigator Award for Pioneering Efforts in ECP Immunomodulation Staines-Upon-Thames, England (ots/PRNewswire) - EUR50,000 award goes to Newcastle University, in collaboration with Medical University, Graz and Newcastle Hospitals NHS Foundation Trust Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced the recipient of 2019's Advancing Extracorporeal Photopheresis (ECP) Immunomodulation ... more
20.03.2018 – 09:02 Mallinckrodt Announces First Investigator Award for Pioneering Efforts in ECP Immunomodulation Staines-Upon-Thames, England (ots/PRNewswire) - EUR50,000 award goes to Rotherham NHS Foundation Trust Department of Haematology Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced the inaugural recipient of its Advancing Extracorporeal Photopheresis (ECP) Immunomodulation Investigator Award. The winning entry was submitted by ... more
